854056-07-8
Chemical Structure
Ropivacaine mesylate
- CAS No.: 854056-07-8
- Formula:C18H30N2O4S
- Molecular Weight:370.51
IUPAC Name: (S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide methanesulfonate
InChIKey: YPTSIOMXZOPKAF-RSAXXLAASA-N
SMILES: O=C([C@H]1N(CCC)CCCC1)NC2=C(C)C=CC=C2C.CS(=O)(O)=O
Biological Activity: Ropivacaine mesylate is a long-acting amide local anaesthetic agent for a spinal block and effectively blocks neuropathic pain. Ropivacaine blocks impulse conduction via reversible inhibition of sodium ion influx in nerve fibressup[1][2]. Ropivacaine is also an inhibitor of K2P (two-pore domain potassium channel) TREK-1 with an IC50 of 402.7 μM in COS-7 cell's membrane[3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ropivacaine mesylate | 99.51% | Ropivacaine mesylate is a long-acting amide local anaesthetic agent for a spinal block and effectively blocks neuropathic pain. Ropivacaine blocks impulse conduction via reversible inhibition of sodium ion influx in nerve fibressup. Ropivacaine is also an inhibitor of K2P (two-pore domain potassium channel) TREK-1 with an IC50 of 402.7 μM in COS-7 cell's membrane. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.90
HY-B0563Ropivacaine -
Similarity Score 0.90
HY-B0563BRopivacaine hydrochloride -
Similarity Score 0.90
HY-W099429Ropivacaine impurity 1 hydrochloride -
Similarity Score 0.89
HY-B0563ARopivacaine hydrochloride monohydrate -
Similarity Score 0.84
HY-W415121Bupivacaine hydrochloride monohydrate -
Similarity Score 0.84
HY-B0405Bupivacaine -
Similarity Score 0.84
HY-B0653Levobupivacaine -
Similarity Score 0.84
HY-B0405ABupivacaine hydrochloride -
Similarity Score 0.84
HY-B0653ALevobupivacaine hydrochloride -
Explore the MedChemAI to find more analogs
References
- [1]. Li TF, et al. Epidural sustained release ropivacaine prolongs anti-allodynia and anti-hyperalgesia in developing and established neuropathic pain. PLoS One. 2015 Jan 24;10(1):e0117321. [Content Brief]
- [2]. Milan Patel, et al. Ropivacaine Inhibits Pressure-Induced Lung Endothelial Hyperpermeability in Models of Acute Hypertension. Life Sci. 2019 Apr 1;222:22-28. [Content Brief]
- [3]. Dene Simpson, et al. Ropivacaine: a review of its use in regional anaesthesia and acute pain management. Drugs. 2005;65(18):2675-717. [Content Brief]
